Pruritus Treatment Pipeline Research 2024: Comprehensive Insights about 20+ Companies and 25+ Drugs - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Pruritus - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Pruritus - Pipeline Insight, 2024" report...

Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001 Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Uremic Pruritus - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...

Pruritus Therapeutics Market Analysis Reveals Promising Growth Opportunities by 2030 Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Pruritus Therapeutics Market by Therapy (Antihistamines, Calcineurin Inhibitors, Corticosteroids), Disease Indication (Allergic Contact...

Pruritus Therapeutics Market to Reach USD 12.6 Billion by 2032, Poised for Steady 4.1% CAGR  New York, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to marketresearch.biz, the estimated size of the global pruritus therapeutics market in 2022 was USD 8.5 billion, and it is expected to exhibit...

Global Chronic Pruritus Therapeutics Market Size To Surpass USD 12.1 Billion By 2030 | CAGR of 4.4% New York, United States , April 17, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Pruritus Therapeutics Market Size is To Grow from USD 8.2 Billion in 2021 to USD 12.1 Billion by 2030, at a Compound...